<unk> , sold under the brand name Orbactiv among others, is a semisynthetic glycopeptide antibiotic medication for the treatment of serious Gram-positive bacterial infections. Its chemical structure as a lipoglycopeptide is similar to vancomycin. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved<unk>  for treatment of acute bacterial skin and skin structure infections.
Oritavancin
Rifampicin
Amikacin
Telithromycin
Dalbavancin
Milbemycin
Moxifloxacin
Milbemycin oxime